As a member of the firm's FDA, Healthcare and Life Sciences practices groups, she advises pharmaceutical and medical device companies on regulatory compliance as well as represents them in large scale litigations. Jenny is also a student in Columbia University's Masters in Bioethics program which she will complete in Spring 2017. Prior to joining Gibson Dunn, Jenny received her Juris Doctorate from New York University, School of Law and her Bachelors in Science in Biology/Genetics from the University of California, San Diego where she was elected to Phi Beta Kappa.